Two findings [29, 30] demonstrated that circulating and intratumoral PD1+CD8+ T-cells are related to worse response and survival outcomes, and serve as an independent adverse prognostic indicator in gastric cancer, which are contrary to the results of the other two studies [31, 32]. This evidence concerns the gene PDCD1 and gastric cancer.